Literature DB >> 30308531

Risk of Gonococcal Infection During Vaginal Exposure is Associated With High Vaginal pH and Active Menstruation.

Stephanie E McLaughlin, Khalil G Ghanem, Jonathan M Zenilman, J McLeod Griffiss1.   

Abstract

BACKGROUND: An understanding of the biological reasons why 25% to 35% of women resist infection during vaginal intercourse with a man infected with Neisseria gonorrhoeae could lead to novel control measures. We sought modifiable biological bases for infection resistance by comparing women in the same core-mixing group who did or did not become infected after sexual exposure.
METHODS: We enrolled 61 female contacts of index men with gonorrhea seen at Baltimore City Health Department clinics from January 2008 through May 2012. Exposure and sexual practices and histories, co-infections, physical signs on exam, patient symptom report, and menstrual history were collected.
RESULTS: Thirty-eight (62.3%) of the exposed women developed cervical infections. Multiple logistic regression found that a vaginal pH of 4.5 or higher at presentation to clinic was significantly associated with gonococcal infection (adjusted odds ratio, 5.5; P = 0.037) in women who presented within one menstrual cycle, 35 days. In this group of women, there was a significant association between acquiring an N. gonorrhoeae cervical infection and sexual exposure during menstruation (adjusted odds ratio 12.5; P = 0.05).
CONCLUSIONS: Modification of vaginal pH could be explored as novel strategy for reducing the risk of N. gonorrhoeae infections in women.

Entities:  

Mesh:

Year:  2019        PMID: 30308531      PMCID: PMC6892601          DOI: 10.1097/OLQ.0000000000000926

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  22 in total

1.  A study of cervical cultures taken in cases of acute gonorrhea with special reference to the phases of the menstrual cycle.

Authors:  M L KOCH
Journal:  Am J Obstet Gynecol       Date:  1947-11       Impact factor: 8.661

2.  Vaginal physiology during menstruation.

Authors:  G Wagner; B Ottesen
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

3.  Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population.

Authors:  Roberta B Ness; Kevin E Kip; David E Soper; Sharon Hillier; Carol A Stamm; Richard L Sweet; Peter Rice; Holley E Richter
Journal:  Sex Transm Dis       Date:  2005-07       Impact factor: 2.830

Review 4.  The development and use of the concept of a sexually transmitted disease core.

Authors:  J C Thomas; M J Tucker
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

5.  Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea.

Authors:  R Platt; P A Rice; W M McCormack
Journal:  JAMA       Date:  1983-12-16       Impact factor: 56.272

6.  Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.

Authors:  F A Plummer; J N Simonsen; H Chubb; L Slaney; J Kimata; M Bosire; J O Ndinya-Achola; E N Ngugi
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

7.  Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae.

Authors:  W M McCormack; G H Reynolds
Journal:  JAMA       Date:  1982-03-05       Impact factor: 56.272

8.  Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae.

Authors:  W R McKenna; P A Mickelsen; P F Sparling; D W Dyer
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

9.  The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection.

Authors:  E Lycke; G B Löwhagen; G Hallhagen; G Johannisson; K Ramstedt
Journal:  Sex Transm Dis       Date:  1980 Jan-Mar       Impact factor: 2.830

10.  Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles.

Authors:  Guido Lopes Dos Santos Santiago; Piet Cools; Hans Verstraelen; Marijke Trog; Griet Missine; Nabil El Aila; Rita Verhelst; Inge Tency; Geert Claeys; Marleen Temmerman; Mario Vaneechoutte
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.